UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
May 1, 2019
Date of Report (date of earliest event reported)
 
 
ASCENA RETAIL GROUP, INC.
(Exact name of Registrant as specified in its charter)
 
 
 
 
Delaware
0-11736
30-0641353
(State or other jurisdiction of
incorporation)
(Commission File Number)
(IRS Employer
Identification Number)
 
933 MacArthur Boulevard
Mahwah, New Jersey 07430
(Address of principal executive offices, including zip code)
 
(551) 777-6700
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company o
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o





 






Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Retirement of Chairman and Chief Executive Officer

On May 1, 2019, Ascena Retail Group, Inc. (the “Company”) announced the retirement of David Jaffe as the Company’s Chairman and Chief Executive Officer, effective as of that date. Mr. Jaffe will continue to serve as a member of the Company’s Board of Directors (the “Board”) following his retirement. In addition, Mr. Jaffe will remain an employee of the Company and serve as a senior advisor to Gary Muto, the newly-appointed Chief Executive Officer of the Company, through June 28, 2019, at which time Mr. Jaffe’s retirement as an employee of the Company will become effective. While serving as a senior advisor, Mr. Jaffe’s will be paid a salary at the annualized rate of $250,000.

In connection with Mr. Jaffe’s retirement, the Company and Mr. Jaffe entered into a transition and separation agreement and general release, pursuant to which Mr. Jaffe will be entitled to receive severance in accordance with the terms of his employment offer letter with the Company dated as of July 29, 2017, which provides for the following payments and benefits:

continued payment of Mr. Jaffe’s base salary for a period of 24 months following termination;
Company-paid COBRA continuation coverage for up to 18 months, subject to his continued payment of premiums at the applicable active rate, plus a payment of $2,000 per month from the Company; and
a lump sum payment equal to the Spring season short-term incentive award Mr. Jaffe would be entitled to receive, based on actual performance and pro-rated for the portion of the Spring season that Mr. Jaffe was employed.

In addition, as of June 27, 2019, Mr. Jaffe will satisfy the “Total Years Test” with respect to any then outstanding stock options and restricted stock units granted to him under the Company’s 2016 Omnibus Incentive Plan, as amended (the “2016 Plan”) (and any predecessor plan). Subject to Mr. Jaffe’s continued service as a senior advisor through June 28, 2019, as a result of satisfying the Total Years Test, Mr. Jaffe’s outstanding stock options will continue to vest in accordance with their terms and all of Mr. Jaffe’s outstanding restricted stock units will become immediately vested.

The foregoing description of the transition and separation agreement and general release with Mr. Jaffe is qualified in its entirety by reference to the transition and separation agreement and general release, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Appointment of Chief Executive Officer and Director

On May 1, 2019, the Company announced the appointment of Gary Muto, 59, as the Company’s Chief Executive Officer and a member of the Board, succeeding David Jaffe, who is retiring as Chairman and Chief Executive Officer of the Company, effective as of that date. Mr. Muto will join the Board as a member of the class of directors whose terms of office expire at the Company’s 2021 Annual Meeting of Stockholders.

Prior to his appointment as Chief Executive Officer, Mr. Muto served as President and Chief Executive Officer-ascena Brands since August 2017, and previously served as President and Chief Executive Officer of the Company’s Premium Fashion segment. Mr. Muto joined ANN INC. in 2008 as the President of LOFT, and in 2013 assumed responsibility for leading the Ann Taylor, LOFT and Lou & Grey brands. Between 1998 and 2007, Mr. Muto held several leadership roles at Gap Inc., including President of Banana Republic and President of Gap brands.

In connection with Mr. Muto’s appointment as Chief Executive Officer, the Company and Mr. Muto entered into an employment offer letter, dated as of May 1, 2019 (the “Muto Offer Letter”), which supersedes Mr. Muto’s June 1, 2017 employment offer letter with the Company. The material terms of the Muto Offer Letter are summarized below.

Pursuant to the Muto Offer Letter, Mr. Muto will continue to receive a base salary of $1,000,000 per year and will be eligible to participate in the Company’s seasonal performance-based incentive compensation program at a target level of 150% of Mr. Muto’s base salary (with a maximum payout opportunity of 200% of target, or $3,000,000).

Simultaneously with the execution of the Muto Offer Letter, Mr. Muto received a one-time long-term incentive award of performance-based equity (the “Promotion Grant”) under the 2016 Plan. The Promotion Grant has a grant date value of $3,850,000, with approximately 60% of the value granted in the form of performance-based restricted stock units (“RSUs”) and approximately 40% of the value granted in the form of performance-based non-qualified stock options (“NQSOs”). Subject to Mr. Muto’s continued employment, the RSUs and NQSOs subject to the Promotion Grant will be eligible to vest as follows:






25% of each of the RSUs and NQSOs will be eligible to vest if the closing price of the Company’s common stock equals or exceeds $3.00 per share for a 20-consecutive trading day period on or prior to the third anniversary of the grant date (the “$3 Hurdle”);
an additional 25% of each of the RSUs and NQSOs will be eligible to vest if the closing price of the Company’s common stock equals or exceeds $5.00 per share for a 20-consecutive trading day period on or prior to the third anniversary of the grant date (the “$5 Hurdle”); and
the remaining 50% of each of the RSUs and NQSOs will be eligible to vest if the closing price of the Company’s common stock equals or exceeds $7.00 per share for a 20-consecutive trading day period on or prior to the third anniversary of the grant date (the “$7 Hurdle” and collectively with the $3 Hurdle and $5 Hurdle, the “Hurdles”).

If a Hurdle is actually achieved prior to the second anniversary of the grant date of the Promotion Grant, the portion of the RSUs and NQSOs related to the Hurdle that was achieved prior to the second anniversary will vest on the second anniversary, subject to Mr. Muto’s continued employment. Any portion of the RSUs and NQSOs related to a Hurdle that is not actually achieved by the third anniversary of the grant date will be forfeited for no consideration. As a condition to the receipt of the Promotion Grant, Mr. Muto must execute a restrictive covenant agreement containing non-competition, non-solicitation and other provisions.

If Mr. Muto’s employment is terminated by the Company without “Cause” or Mr. Muto resigns for “Good Reason” (each as defined in the Muto Offer Letter), in each case prior to a change in control of the Company, he will become vested in a pro-rata portion of the RSUs and NQSOs for which the applicable Hurdle was achieved prior to his termination.

If Mr. Muto’s employment with the Company terminates due to his death or disability prior to the second anniversary of the grant date of the Promotion Grant, Mr. Muto (or his estate or legal representative, as applicable) will receive full vesting of the RSUs and NQSOs for which the applicable Hurdle was actually achieved prior to his termination due to death or disability.

If Mr. Muto has a “Change in Control Related Termination” (as defined in the Executive Severance Plan) on or within 24 months following a change in control, and on or prior to the date of such termination the $3 Hurdle was actually achieved, Mr. Muto will become vested in a portion of the RSUs and NQSOs based on linear interpolation between the closing price of the Company’s common stock for the 20-consecutive trading day period immediately preceding the date of Mr. Muto’s termination (the “Termination Date Price”) and the Hurdles between which the Termination Date Price falls. If Mr. Muto has a Change in Control Related Termination within 90 days prior to a change in control, and on or prior to the date that the change in control is consummated the $3 Hurdle is achieved, the cash payment Mr. Muto is entitled to receive pursuant to the Executive Severance Plan (as in effect on June 1, 2017) will include payment in respect of a portion of the RSUs and NQSOs based on linear interpolation between the closing price of the Company’s common stock for the 20-consecutive trading day period immediately preceding the change in control (the “CIC Closing Date Price”) and the Hurdles between which the CIC Closing Date Price falls.

The long term incentive awards granted to Mr. Muto prior to May 1, 2019 will remain outstanding and eligible to vest in accordance with their terms. Mr. Muto will also continue to participate in the Company’s Transformation Bonus Program.

Mr. Muto will continue to be a participant in the Company’s Executive Severance Plan, subject to the terms and conditions of the Executive Severance Plan (as in effect on June 1, 2017), with certain modifications, including that his cash severance payment level relating to a non-change in control termination will be 24 months of base salary, and his cash severance level relating to a change in control related termination will be 24 months of base salary and bonus.

The foregoing description of the Muto Offer Letter is qualified in its entirety by reference to the Muto Offer Letter, which is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated herein by reference.

Appointment of Interim Executive Chair of the Board

On May 1, 2019, the Company announced the appointment of Carrie Teffner, 52, as Interim Executive Chair of the Board (“Interim Chair”), effective as of that date.

Ms. Teffner has been a member of the Board since 2018. Ms. Teffner served as Executive Vice President Finance and Strategic Projects of Crocs, Inc. (“Crocs”) from August 2018 to April 2019, and served as Executive Vice President and Chief Financial Officer of Crocs from December 2015 to August 2018. Prior to joining Crocs, Ms. Teffner served as Executive Vice President and Chief Financial Officer of PetSmart, Inc. from 2013 to 2015 until it was sold to BC Partners, where she was responsible for finance and information technology. Ms. Teffner also served as Executive Vice President and Chief Financial Officer of Weber Stephen Products LLC from 2011 to 2013. From 2009 to 2011, Ms. Teffner served as Senior Vice President and Chief Financial Officer of The Timberland Company until it was sold to VF Corporation. Ms. Teffner spent the first 21 years of her career with Sara Lee Corporation where she held various domestic and international positions including divisional and segment Chief Financial Officer.






In connection with Ms. Teffner’s appointment as Interim Chair, the Company and Ms. Teffner entered into an employment offer letter, dated as of May 1, 2019 (the “Teffner Offer Letter”). The material terms of the Teffner Offer Letter are summarized below.

Ms. Teffner will receive a base salary at the annualized rate of $1,000,000 and will be eligible to participate in the Company’s seasonal performance-based incentive compensation program at a target level of 150% of Ms. Teffner’s base salary (with a maximum payout opportunity of 200% of target, or $3,000,000).

Simultaneously with the execution of the Teffner Offer Letter, Ms. Teffner received a one-time long-term incentive award of performance-based equity (the “Appointment Grant”) under the 2016 Plan. The Appointment Grant has a grant date value of $1,050,000, with approximately 60% of the value granted in the form of performance-based RSUs and approximately 40% of the value granted in the form of performance-based NQSOs. Subject to Ms. Teffner’s continued employment as Interim Chair or service as a member of the Board, the RSUs and NQSOs subject to the Appointment Grant will be eligible to vest in accordance with the same vesting schedule that applies to Mr. Muto’s Promotion Grant. As a condition to the receipt of the Appointment Grant, Ms. Teffner must execute a restrictive covenant agreement containing non-competition, non-solicitation and other provisions.

If Ms. Teffner’s employment as Interim Chair ends due to the appointment of a Non-Executive Chair and Ms. Teffner continues to serve on the Board, the RSUs and NQSOs granted pursuant to the Appointment Grant will remain outstanding and eligible to vest.

If, prior to a change in control, (i) the Company terminates Ms. Teffner’s employment as Interim Chair without “Cause” (as defined in the 2016 Plan) and Ms. Teffner does not continue to serve as a member of the Board or (ii) Ms. Teffner has a “Termination of Directorship” (as defined in the 2016 Plan) other than due to her resignation or her removal for “cause” under Delaware law, she will become vested in a pro-rata portion of the RSUs and NQSOs for which the applicable Hurdle was achieved prior to her termination.

In the event of Ms. Teffner’s termination as Interim Chair or as a member of the Board due to her death or “Disability” (as defined in the 2016 Plan) prior to the second anniversary of the grant date of the Appointment Grant, Ms. Teffner (or her estate or legal representative, as applicable) will receive full vesting of the RSUs and NQSOs for which the applicable Hurdle was actually achieved prior to her termination due to death or disability.

If, upon a change in control, (i) Ms. Teffner’s employment as Interim Chair is terminated by the Company without Cause and Ms. Teffner does not continue to serve as a member of the Board or (ii) Ms. Teffner has a Termination of Directorship (other than due to her resignation or her removal for “cause” under Delaware law), in either case while serving on the Board after her employment as Interim Chair ends due to the appointment of a Non-Executive Chair, and on or prior to the date of such termination, the $3 Hurdle was actually achieved, Ms. Teffner will become vested in a portion of the RSUs and NQSOs based on linear interpolation between the Termination Date Price and the Hurdles between which the Termination Date Price falls.

The foregoing description of the Teffner Offer Letter is qualified in its entirety by reference to the Teffner Offer Letter, which is filed as Exhibit 10.3 to this Current Report on Form 8-K and is incorporated herein by reference.

Retention Agreement with Executive Vice President and Chief Financial Officer

On May 1, 2019, the Company entered into a retention agreement with Robb Giammatteo, the Company’s Executive Vice President and Chief Financial Officer, pursuant to which Mr. Giammatteo is eligible to receive a retention bonus of up to $700,000. The retention bonus will be paid to Mr. Giammatteo in equal installments on August 31, 2019 and August 31, 2020, subject to Mr. Giammatteo’s employment on each such date. In addition, Mr. Giammatteo’s severance in the event of a “Non-Change in Control Termination” (as defined in the Executive Severance Plan) will be equal to 24 months of his base salary, and the multiple of his cash severance amount in the event of a “Change in Control Related Termination” (as defined in the Executive Severance Plan) will be two times. 

The foregoing description of the retention agreement with Mr. Giammatteo is qualified in its entirety by reference to the retention agreement, which is filed as Exhibit 10.4 to this Current Report on Form 8-K and is incorporated herein by reference.

Departure of President and Chief Operating Officer

On May 1, 2019, the Company announced that Brian Lynch, the Company’s President and Chief Operating Officer, was departing. In connection with Mr. Lynch’s departure, the Company has provided Mr. Lynch with a separation agreement and general release pursuant to which Mr. Lynch would receive severance benefits under the Company’s Executive Severance Plan and Mr. Lynch’s





April 5, 2019 employment offer letter with the Company. Under such separation agreement, if entered into, he would be entitled to receive (i) an amount equal to 52 weeks of his current base salary, paid in installments in accordance with the Company’s payroll practices, (ii) Company-paid COBRA continuation coverage for up to 12 months, less the active employee rate for Mr. Lynch and his eligible dependents, (iii) up to 12 months of executive outplacement services at a cost to the Company not to exceed $7,300, (iv) a lump sum payment equal to the Spring season short-term incentive award Mr. Lynch would be entitled to receive, based on actual performance and pro-rated for the portion of the Spring season Mr. Lynch was employed, and (v) a lump sum payment equal to Mr. Lynch’s base salary for the period from May 2, 2019 through September 30, 2019. Mr. Lynch is subject to post-employment non-competition and employee and customer non-solicitation restrictions.


Item 8.01 Other Events.

On May 1, 2019, the Company issued a press release announcing Mr. Jaffe’s retirement as the Company’s Chairman and Chief Executive Officer and the appointment of his successor, Mr. Muto, in addition to other related matters. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits .

Exhibit No.
 
Description
 
David Jaffe Transition and Separation Agreement and General Release, dated May 1, 2019.
 
Gary Muto Employment Offer Letter, effective May 1, 2019.
 
Carrie Teffner Employment Offer Letter, effective May 1, 2019.
 
Robb Giammatteo Retention Agreement, effective May 1, 2019.
 
Press Release issued May 1, 2019.







SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ASCENA RETAIL GROUP, INC.
(Registrant)

Date: May 1, 2019

By:
/s/ Dan Lamadrid
Dan Lamadrid
Senior Vice President and Chief Accounting Officer
(Principal Accounting Officer)



EXECUTION VERSION May 1, 2019 VIA HAND DELIVERY David Jaffe Dear David: This Transition and Separation Agreement and General Release (“Agreement”) will confirm the terms of your retirement from Ascena Retail Group, Inc. (the “Company”) at the request of the Company’s Board of Directors (the “Board”) on mutually agreeable terms as set forth below. For the purposes of this Agreement, the Company also includes any parent, affiliates, predecessors, successors, subsidiaries, and other related entities and each of their past and/or present officers, directors, employees, and agents. You and the Company (collectively, the “Parties”) agree that this Agreement represents the full and complete agreement concerning your separation from employment with the Company. 1. Transition Date: Effective May 1, 2019 (the “Transition Date”), you will retire as the Company’s Chairman and Chief Executive Officer, although you will continue to serve as a member of the Board following the Transition Date. Effective on the Transition Date, you hereby resign from any and all positions you hold at the Company, including all positions you hold as an officer, director or fiduciary, other than your position as a member of the Board, and you agree to execute the resignation letters attached hereto as Exhibit A as well as such other resignation letters reasonably requested by the Company. Provided you execute this Agreement, from the Transition Date through June 28, 2019 (such period, the “Advisory Period”), you will continue to serve as an employee of the Company, and will be a senior advisor to the Company’s Chief Executive Officer. During the Advisory Period, you will be expected to perform, and you will perform, services equal to 25% of the average level of bona fide services that you provided to the Company prior to the Transition Date (the intent of the foregoing is that you will not incur a “separation from service,” within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), during the Advisory Period). During the Advisory Period, you will provide such services as you and the Chief Executive Officer and/or the Interim Executive Chair deem mutually and reasonably appropriate. In consideration for providing services during the Advisory Period, you will be receive a salary at the annualized rate of $250,000, payable in accordance with the Company’s normal payroll practices and subject applicable withholdings. Your last day of employment with the Company will be Friday, June 28, 2019 (the “Separation Date”), at which time you will incur a “separation from service” within the meaning of Section 409A. On the Separation Date, regardless of whether you sign this Agreement, you will receive your base salary through the Separation Date, less applicable withholding. In addition, regardless of whether you sign this Agreement, you will be entitled to receipt of your vested 107624016v8


 
account balance under the Company’s Executive Retirement Plan (the “ERP”), payable to you in accordance with your deferral elections under the ERP (for the avoidance of doubt, the Parties stipulate that your deferral election is to receive a cash lump sum) and subject to a six-month delay pursuant to Section 409A of the Code, such that, for purposes of clarity, you will receive your entire account balance under the ERP on Thursday, January 2, 2020. 2. Consideration: Provided that you sign and return this Agreement without revoking it as set forth in Paragraph 26 of this Agreement and provided further that you sign and return the supplemental release attached hereto as Annex 1 without revoking it as set forth in Paragraph __ of the supplemental release, the Company will, following your Separation Date: (a) Pay you the equivalent of 24 months of pay (the “Severance Period”) at your annual rate of salary of $1,000,000 (for clarity, for an aggregate amount of $2,000,000), less applicable withholding. This amount will be paid in substantially equal installments during the Severance Period on the same bi-weekly pay schedule as the Company’s payroll, beginning with the first normal pay period after your Separation Date. Although the Company does not guarantee any particular tax treatment relating to the payments and benefits to be provided to you under this Agreement, it is the intent of the Parties that all payments and benefits under this Agreement comply with or be exempt from Section 409A of the Code and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith. The Parties agree to reasonably cooperate to take all further actions necessary to satisfy the requirements of Section 409A of the Code. (b) Subject to your and/or your covered dependents’, as applicable, timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), and your or your covered dependents’, as applicable, continued payment of premiums at the same level and cost as if you were an employee of the Company (excluding, for purposes of calculating cost, an employee’s ability to pay premiums with pre-tax dollars), for a period though the earlier of (x) the applicable period that you and/or your covered dependents, as applicable, are eligible for continuation coverage under COBRA and (y) you becoming eligible for coverage under the health and medical insurance plans of a subsequent employer, (1) provide you and your eligible dependents continued participation in the Company’s (or its successors) health and medical insurance plans (to the extent permitted under applicable law and the terms of such plan), in a manner intended to avoid any excise tax under Section 4980D of the Code and (2) pay you $2,000 per month for each month you and your covered dependents receive COBRA (but in no event shall the payments exceed $36,000), less applicable withholding; and (c) Pay you a lump sum, less applicable withholding, which is equivalent to the amount that you would have been eligible to receive under the Spring season short-term incentive bonus plan, as in effect and as that program may be modified, from time to time, based on actual achievement of the performance goals established for the Spring season, had you been employed by the Company at the time that payments to active employees are made in or about September/October 2019, prorated as applicable based upon your service - 2 - 107624016v8


 
from the start of the Spring season through the Separation Date and based on a blended rate of your base salary in effect prior to the Transition Date and your base salary in effect from the Transition Date through the Separation Date. The Parties agree that this payment will be made no earlier than the time that payments to active employees are made under the applicable seasonal short-term incentive bonus plan; provided, however, that, notwithstanding the foregoing, this payment will, in all events, be paid no later than the end of the “applicable 2 ½ month period” under Treasury Regulation Section 1.409A- 1(b)(4), issued pursuant to Section 409A. 3. Withholding on Payments: Taxes, applicable withholding and authorized or required deductions will be deducted from all payments to you. 4. Employee Benefits: Except as expressly provided herein and/or as otherwise required by law, your employee benefits, including but not limited to medical/hospitalization and dental insurance benefits, life insurance, short-term disability and long-term disability insurance coverage, and 401(k) plan participation, will terminate on your Separation Date. 5. COBRA: Following your Separation Date, you may elect to continue any employer- sponsored group health plan coverage you may have at your own expense, except as otherwise provided in Paragraph 2(b) of this Agreement, pursuant to a federal law known as COBRA. You will receive, under separate cover, information regarding continuing your coverage pursuant to COBRA. Additionally, you may have other options available to you when you lose group health plan coverage. For example, you may be eligible to buy an individual plan through the Health Insurance Marketplace, where you may qualify for lower costs on your monthly premiums and lower out-of-pocket costs, provided that you enroll in Marketplace coverage within limited time periods following your Separation Date. Additionally, you may qualify for a 30-day special enrollment period for another group health plan for which you are eligible (such as a spouse’s plan), even if that plan generally doesn’t accept late enrollees. Additionally, if you or any of your dependents are eligible to enroll in Medicare, you are solely responsible for determining how any COBRA coverage you elect is affected by Medicare eligibility, and how, when and under what conditions you may enroll in Medicare without any penalty. You are responsible for your selection of health coverage following your Separation Date and the Company has no obligation or liability with respect to such coverage. 6. Stock Options and Restricted Stock Units: Provided you remain employed by the Company through the end of the Advisory Period, you will satisfy the “Total Years Test” with respect to the stock options and restricted stock units granted to you under the Company’s 2016 Omnibus Incentive Plan, as amended (and any predecessor plan) (the “2016 Plan), that are outstanding and unvested as of the Separation Date. The Company agrees not to terminate your employment without Cause prior to the Separation Date. As a result of satisfying the Total Years Test, (i) all stock options that are outstanding and unvested as of the Separation Date will continue to vest in accordance with the terms of the 2016 Plan and the award agreement(s) thereunder and options that become vested on or after the Separation Date will remain exercisable for four years (but in no event beyond the expiration date of the stock option) and (ii) all restricted stock units that are outstanding and unvested as of the Separation Date will become fully vested and will be settled in accordance with the terms of the 2016 Plan and the applicable award agreement(s) thereunder. - 3 - 107624016v8


 
7. Accrued Vacation: You will be paid for all accrued but unused vacation if required by the applicable policy under which the vacation was earned. You understand that you are entitled to this payment regardless of whether you sign this Agreement. 8. No Interference with Rights: The Parties agree that nothing in this Agreement shall be construed to prohibit you from challenging illegal conduct and/or engaging in protected activity, including without limitation filing a charge or complaint with, and/or participating in any investigation or proceeding conducted by, the Equal Employment Opportunity Commission (the “EEOC”), the National Labor Relations Board (the “NLRB”), the Securities and Exchange Commission (the “SEC”), and/or any other federal, state, or local government agency. Further, the Parties agree that nothing in this Agreement shall be construed to interfere with the ability of any federal, state, or local government agency to investigate any such charge or complaint, or your ability to communicate voluntarily with, including providing documents or other information to, any such agency. However, by signing this Agreement, you understand that you are waiving your right to receive individual relief (including without limitation back pay, front pay, reinstatement, or other legal or equitable relief) based on claims asserted in any such charge or complaint, except where such a waiver is prohibited and except for any right you may have to receive a payment from a government agency (and not the Company) for information provided to the government agency. You understand that your release of claims as contained in this Agreement does not extend to any rights you may have under any laws governing the filing of claims for COBRA, unemployment, disability insurance, and/or workers’ compensation benefits. You further understand that nothing herein shall be construed to prohibit you from: (a) challenging the Company’s failure to comply with its promises to make payment and provide other consideration under this Agreement; (b) asserting your right to any vested benefits to which you are entitled pursuant to the terms of the applicable plans and/or applicable law; (c) challenging the knowing and voluntary nature of your release of claims under the Age Discrimination in Employment Act; (d) asserting any claim that cannot lawfully be waived by private agreement; and/or (e) asserting any claim that may arise after the date this Agreement was signed. Nothing in this Agreement shall be construed to prohibit you from reporting an event that you reasonably and in good faith believe is a violation of law to the relevant law- enforcement agency (including but not limited to the EEOC, Department of Justice, the SEC, Congress, the Department of Labor, and any Inspector General), from cooperating in an investigation conducted by such a government agency, or making other disclosures that are protected under the whistleblower provisions of any law or regulation. This may include disclosure of trade secret or confidential information within the limitations permitted by the 2016 Defend Trade Secrets Act (the “DTSA”). You are hereby provided notice that under the DTSA, (1) no individual will be held criminally or civilly liable under federal or state trade secret law for the disclosure of a trade secret (as defined in the Economic Espionage Act) that: (A) is made in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and made solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal so that it is not made public; and, (2) an individual who pursues a lawsuit for retaliation by an employer for reporting a suspected violation of the law may disclose the - 4 - 107624016v8


 
trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal, and does not disclose the trade secret, except as permitted by court order. 9. Reimbursement of Business Expenses: As soon as practicable after the Transition Date but in no event later than 2 weeks of your Separation Date, you agree to submit appropriate documentation of all authorized business expenses incurred in connection with your performance of duties for the Company, and the Company will reimburse you in accordance with Company policy. You should submit such documentation to the head of Human Resources for the Company. 10. Cooperation: Except as otherwise provided in Paragraph 8 of this Agreement, after your Separation Date, you agree to be reasonably available during normal business hours upon reasonable advanced requests to cooperate (but only truthfully) with the Company and provide information as to matters which you were personally involved, or have information on, during your employment with the Company and which are or become the subject of litigation or other dispute. In the event of such cooperation, you shall be reimbursed for your reasonable expenses in connection therewith. 11. No Other Payments: You understand and agree that absent this Agreement, you would not otherwise be entitled to the consideration specified in this Agreement. Further, by signing this Agreement, you agree that you are not entitled to any payments and/or benefits that are not specifically listed in this Agreement, including but not limited to benefits under the Company’s Executive Severance Plan, the 2012 Cash Incentive Plan and/or any other bonus payment plans, and the Long Term Incentive Program. You will, however, be entitled to such benefits as are provided for under the tax qualified retirement plans and non-qualified plans for the Company in which you have (or will have) a vested right, such as the 2016 Plan, the 401(k) plan and the ERP. You further agree and acknowledge that upon the Company’s providing the payments and other benefits set forth in this Agreement, the Company has paid you in full any and all monies owed to you in connection with your employment with the Company and separation from employment, including but not limited to payment for all services performed on behalf of the Company, except as otherwise specifically stated in this Agreement. 12. General Release of All Claims: Except as otherwise provided in this Agreement and with respect to the payments and benefits set forth in this Agreement, you acquit, release, and forever discharge the Company of and from all actions and causes of action, suits, debts, claims, and demands which may legally be waived by private agreement, in law or in equity, which you ever had, or may now have, with respect to any aspect of your employment by, and/or separation of employment from, the Company, whether known or unknown to you at the time of execution of this Agreement, including, but not limited to, claims for breach of contract (express or implied), personal injury, defamation and wrongful discharge; claims based on any oral or written agreements or promises, contract, constitutional provision, common law, public policy, and tort; claims for retaliation, and/or discrimination or harassment in employment; and claims for compensatory, actual, special, consequential, reliance, punitive, exemplary and/or other damages for personal injuries, pain and suffering, emotional distress, health care expenses, back pay, front pay, separation pay, wages, - 5 - 107624016v8


 
benefits, attorney’s fees, costs, interest or other monies, from the beginning of time through the date that you sign this Agreement. You agree that, except as otherwise provided in Paragraph 8 of this Agreement and except with respect to the payments and benefits set forth in this Agreement, your covenants and releases, as set forth in this Agreement, include a waiver of any and all rights or remedies which you ever had or may now have against the Company, from the beginning of time through the date that you sign this Agreement, under any present and/or future federal, state, local or foreign statute, law, regulation, constitution, and/or common law, including, but not limited to: the New York State Human Rights Law; the New York City Administrative Code; the New York Labor Law; the New York Minimum Wage Act; the statutory provisions regarding retaliation/discrimination under the New York Worker’s Compensation Law; the New York City Earned Sick Time Act; the New York City Human Rights Law; the New Jersey Law Against Discrimination; the New Jersey Family Leave Act; the New Jersey Conscientious Employee Protection Act; the New Jersey Wage Payment Law; the New Jersey Wage and Hour Law; the New Jersey Equal Pay Law; the New Jersey Smoker’s Rights Act; the New Jersey Lie Detector Test Law; the New Jersey Jury Duty Employee Protection Law; the New Jersey Worker Freedom From Intimidation Act; the New Jersey Political Activities of Employees Law; the New Jersey Fair Credit Reporting Act; the retaliation provisions of the New Jersey Workers’ Compensation Law; the New Jersey Security and Financial Empowerment Act; the Millville Dallas Airmotive Plant Job Loss Notification Act; the New Jersey Military Leave Law; the New Jersey Employment Protection for Volunteer Emergency Responder Law; the New Jersey Social Media Privacy law; the New Jersey Opportunity to Compete Act; all Municipal Sick Leave Laws; any claims for violation of the New Jersey State Constitution; the Stop Sexual Harassment in the Workplace Act; Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1866; the Civil Rights Act of 1991; the Americans with Disabilities Act; the Equal Pay Act; the Family and Medical Leave Act; the Employee Retirement Income Security Act; the Age Discrimination in Employment Act; the Older Workers Benefit Protection Act; the Genetic Information Non-Discrimination Act; the Occupational Safety and Health Act; the National Labor Relations Act; the federal Worker Adjustment and Retraining Notification Act; the Consolidated Omnibus Budget Reconciliation Act; the Sarbanes-Oxley Ac of 2002, 18 U.S.C. §1514; Sections 748 (h)(i), 922 (h)(i) and 1057 of the Dodd-Frank Wall Street and Consumer Protection Act (the “Dodd Frank Act”), 7 U.S.C. §26(h), 15 U.S.C. §78u-6(h)(i) and 12 U.S.C. §5567(a), but excluding from this Agreement any right you may have to receive a monetary award from the SEC as an SEC Whistleblower, pursuant to the bounty provision under Section 922(a)-(g) of the Dodd Frank Act, 7 U.S.C. Sec. 26(a)-(g); and any similar federal, state or local statute or law applicable to your employment, all as amended. This Agreement is also intended to and shall release the Company from any and all wage and hour related claims arising out of or in any way connected with your employment with the Company, to the maximum extent permitted by federal and state law. You further acknowledge that as of the date you have signed this Agreement, you have reported any and all work-related illnesses or injuries to the Company. 13. No Claims Filed: Except as otherwise provided in Paragraph 8 of this Agreement, you represent that no claims, complaints or other proceedings are pending in any court or other forum relating directly or indirectly to your employment with the Company and/or separation from employment. - 6 - 107624016v8


 
14. Confidential Information: (a) You agree that you shall not at any time, directly or indirectly, use, make available, sell, disclose or otherwise communicate to any person, other than in the course of your duties and for the benefit of the Company, any business and technical information or trade secrets, nonpublic, proprietary or confidential information, knowledge or data relating to the Company whether the foregoing shall have been obtained by you during your employment by the Company (or any predecessors) or otherwise. The foregoing shall not apply to information that (i) was known to the public prior to its disclosure to you; (ii) becomes generally known to the public subsequent to disclosure to you through no wrongful act by you or any of your representatives; or (iii) you are required to disclose by applicable law, regulation or legal process (provided that you provide the Company with prior notice of the contemplated disclosure and cooperate with the Company at its expense in seeking a protective order or other appropriate protection of such information). (b) You acknowledge that all documents, in hard copy or electronic form, received, created or used by you in connection with employment with the Company are and will remain the property of the Company. Except as otherwise provided in Paragraph 8, you agree to return and/or cooperate in deleting all such documents (including all copies) promptly upon the termination of employment and agree that you will not, under any circumstances, without the prior written consent of the Company, disclose those documents to anyone outside the Company or use those documents for any purpose other than the advancement of the Company’s interests. (c) By signing below, you represent that you have returned to the Company or will return to the Company following the Separation Date any and all confidential information of the Company and all other Company property, including but not limited to: laptops, printers, computers, keys, equipment, identification cards, access card, credit cards, and company car, if applicable; provided, however, that the Company specifically permits you to retain your cell phone and iPad. 15. Indemnification: Indemnification Agreement between you and the Company, dated as of January 1, 2011 (the “Indemnification Agreement”), will survive the termination of your employment on the Separation Date and will remain in effect while you serve as a member of the Board and thereafter in accordance with the terms of the Indemnification Agreement. 16. Nonadmission of Wrongdoing: By entering into this Agreement, neither you nor the Company admits any wrongdoing or violation of law. 17. Restrictive Covenants: You hereby acknowledge and re-affirm the obligations set forth in Section 8 of your employment offer letter with the Company, dated as of July 29, 2017 (the “2017 Letter”) and agree to comply with such provisions, which Section 8 is incorporated by reference herein as if fully set forth herein. Capitalized terms used in this Agreement that are not otherwise defined in this Agreement shall have the meaning ascribed to such terms in the 2017 Letter. - 7 - 107624016v8


 
18. Intellectual Property: You hereby acknowledge and agree to fully and promptly disclose to the Company, without additional compensation, all ideas, original or creative works, inventions, discoveries, computer software or programs, trading strategies, statistical and economic models, improvements, designs, formulae, processes, production methods and technological innovations, whether or not patentable or copyrightable, which, during your employment with the Company, were made, conceived or created by you, alone or with others, during or after usual working hours, either on or off the job, and which are related to the business of the Company or which relate in any way to tasks assigned to you by the Company (“Intellectual Property”). You acknowledge that the Company owns all such Intellectual Property rights as works made for hire to the fullest extent of the law. For the avoidance of doubt, you hereby assign to the Company all such Intellectual Property rights in any and all media now known or hereafter developed, along with all existing causes of action, known or unknown. You agree, at any time during or after employment, to sign all papers and do such other acts and things, at the Company’s expense, as the Company deems necessary or desirable and may reasonably require of you to protect the Company’s rights to such Intellectual Property, including applying for, obtaining and enforcing patents or copyrights with respect to such Intellectual Property in any and all countries. 19. Reasonableness of Restrictions; Right to Injunction: Except as otherwise provided in Paragraph 8 of this Agreement, you expressly acknowledge and agree that the restrictions set forth in this Agreement or incorporated by reference herein are reasonable in all respects and no greater than necessary to protect the Company’s legitimate business interests. You also agree that the Company shall be entitled, as a matter of right, to specific performance of the covenants in this Agreement, including preliminary and permanent injunctive relief, or other appropriate judicial remedy, in any court of competent jurisdiction. Such remedies shall be in addition to all other remedies available to the Company. The Parties further agree that if you have breached any of the terms of Paragraphs 14, 17 and/or 18 of this Agreement, the Company may, at its option, not pay, discontinue paying, and/or recover, as the case may be, any payments set forth in Paragraph 2 of this Agreement, with the exception of Paragraph 2(c), as well as damages, attorneys’ fees, and other costs incurred by the Company in obtaining such relief. 20. Entire Agreement; Modification and Waiver: This Agreement (together with Annex 1 and the provisions of the 2017 Letter incorporated by reference herein) constitutes the entire agreement between the Company and you with respect to the subject matter covered, and supersedes any previous agreement or understandings between you in this regard. This Agreement does not supersede any other agreement(s) unrelated to the subject matter of this Agreement. Both Parties agree that neither has the authority to modify or amend this Agreement unless the modification or amendment is in writing and signed by you and an authorized officer of the Company. The Company’s failure to insist upon strict compliance with any of the terms, covenants or conditions hereof shall not be deemed a waiver of such term, covenant or condition. 21. Judicial Modification: If any court of competent jurisdiction determines that any of the covenants, or any part of any of them, is invalid or unenforceable, the remainder of such covenants and parts thereof shall not be affected and shall be given full effect, without regard to the invalid portion. If any court of competent jurisdiction determines that any of such covenants, or any part thereof, is invalid or unenforceable because of the geographic or temporal scope of - 8 - 107624016v8


 
such provision, such court shall reduce such scope to the minimum extent necessary to make such covenants valid and enforceable. 22. Assignment and Third Party Beneficiaries: You shall not assign any interest in this Agreement or any part thereof without the express written consent of an authorized officer of the Company. The Company may assign this Agreement to, and shall bind, a successor to its business without the requirement of consent by you. Each Affiliate of the Company shall be a third party beneficiary of your obligations under the provisions of this Agreement and shall have the right to enforce this Agreement as if a party hereto. 23. Choice of Law: This Agreement shall be governed by and construed in accordance with the laws of the State of New York. Any dispute arising out of, or relating to this Agreement shall be subject to the exclusive jurisdiction of the state or federal courts of New York. 24. Acknowledgement: By signing this Agreement, you acknowledge that: (a) You have 21 days within which to review and consider signing this Agreement and understand that any changes made to this Agreement, whether material or immaterial, do not restart the 21 day period that you have in which to consider this Agreement; (b) If you sign this Agreement prior to the expiration of the 21 day period, you do so voluntarily and thereby waive the remainder of the 21 day period; (c) By this Paragraph of the Agreement, you have been advised to, and have had the opportunity to, consult with an attorney of your choice prior to signing this Agreement; (d) You have read and fully understand the terms of this Agreement and have knowingly, voluntarily and of your own free will agreed to those terms for the purpose of fully and finally compromising and settling any and all claims, disputed or otherwise, of any kind or nature that you ever had or may now have against the Company arising out of your employment by, and/or separation of employment from, the Company, or otherwise, whether known or unknown to you at the time of execution of this Agreement, except as otherwise provided in Paragraph 8 of this Agreement; (e) You have not relied upon any representation, statement or omission made by any of the Company’s agents, attorneys or representatives with regard to the subject matter, basis or effect of this Agreement or otherwise, other than those expressly stated in this Agreement; (f) You are not waiving any claims that may arise after you execute this Agreement; and (g) The consideration provided to you under Paragraph 2 of this Agreement exceed the amount to which you would have otherwise been entitled as a result of your separation from the Company’s employ and are in exchange for you signing this Agreement. 25. Return of Signed Agreement; Counterparts: You should sign and return this signed Agreement to John Pershing, Executive Vice President, Chief Human Resources Officer, 933 MacArthur Avenue, Mahwah, NJ 07430, or in the alternative, your counsel may provide your signature to counsel for the Company via email, no earlier than the Transition Date, and no later than 21 days from the date you received this Agreement. If you sign or return this Agreement earlier than the Transition Date, or if you do not return the signed Agreement by the date that is 21 days after the date you received this Agreement, this Agreement shall be deemed revoked, null, void and of no effect, and you shall have no entitlement to pay, benefits or any - 9 - 107624016v8


 
consideration as set forth in this Agreement. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which shall constitute one and the same instrument. 26. Revocation Period and Effective Date: You understand and agree that you have 7 calendar days following your execution of this Agreement to revoke it, and that if you elect to revoke it, this Agreement shall be null and void in its entirety. To effectively revoke this Agreement, you must send written notice of your decision to John Pershing, Executive Vice President, Chief Human Resources Officer, 933 MacArthur Avenue, Mahwah, NJ 07430, so that your revocation is received no later than the 8th day after you originally signed this Agreement. You understand that the money and benefits described in Paragraph 2 of this Agreement will not be paid until the expiration of this 7 day period following your execution of the supplemental release attached as Annex 1. 27. Section 409A: (a) A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits that are considered “nonqualified deferred compensation” under Section 409A of the Code upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of employment” or like terms shall mean “separation from service.” If you are deemed on the date of termination to be a “specified employee” within the meaning of that term under Section 409A(a)(2)(B) of the Code, then with regard to any payment or the providing of any benefit made subject to this Section 28(a), to the extent required to be delayed in compliance with Section 409A(a)(2)(B) of the Code, such payment or benefit shall be made or provided as specified below after the date which is the earlier of (i) the expiration of the six-month period measured from the date of the your “separation from service,” and (ii) the date of the your death (the “Delay Period”). Upon the expiration of the Delay Period, all payments and benefits delayed pursuant to this provision (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to you in a lump sum on the first business day following the end of the Delay Period, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein. (b) All expenses or other reimbursements paid pursuant to this Agreement that are taxable income to you shall be paid at the time provided by the Company’s applicable policies and customary practices, but in no event shall be paid later than the end of the calendar year next following the calendar year in which you incur such expense. With regard to any provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by Section 409A of the Code, (i) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (ii) the amount of expenses eligible for reimbursement, of in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in- kind benefits to be provided, in any other taxable year, provided that the foregoing clause - 10 - 107624016v8


 
(ii) shall not be violated with regard to expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement is in effect and (iii) such payments shall be made on or before the last day of your taxable year following the taxable year in which the expense occurred. 28. Supplemental Release: You agree that your entitlement to the payments and benefits set forth in Paragraph 2 of this Agreement is expressly conditioned on his execution of a supplemental release in the form annexed hereto as Annex 1 (the “Supplemental Release”) no earlier than the Separation Date and no later than 21 days after the Separation Date. If you do not execute the Supplemental Release, you will not be entitled to any of the payments or benefits set forth in Paragraph 2. Sincerely, /s/ Kate Buggeln Kate Buggeln Lead Independent Director Read, Accepted and Agreed: /s/ David Jaffe 5/1/19 David Jaffe Date - 11 - 107624016v8


 
May 1, 2019 VIA EMAIL Gary Muto Dear Gary: On behalf of the Board of Directors (the “Board”) of Ascena Retail Group (“Ascena” or the “Company”) I’m excited to offer you a promotion to Chief Executive Officer of the Company! The following are the terms and conditions of our job offer to you and replace any and all previous offers or discussions concerning your employment, effective May 1, 2019 (the “Effective Date”). Job Title: Chief Executive Officer of the Company. On the Effective Date, you will be appointed to the Board. While you are employed by the Company, the Company will nominate you for re-election to the Board each time that your term on the Board would otherwise expire. You agree to resign from the Board upon the termination of your employment for any reason. Duties and Responsibilities: As Chief Executive Officer, you will perform the customary duties and have the customary responsibilities and authorities of such position, as well as such other duties commensurate with such position as may be reasonably assigned to you from time to time by the Board. You agree to faithfully serve Ascena and devote substantially all of your working time, attention and energies to the business of Ascena, its subsidiaries and affiliated entities. You agree not to engage in any other business or employment without the written consent of the Board except as otherwise specifically provided herein. You may perform uncompensated services in connection with either the management of personal investments or with charitable or civic organizations, provided that such activities do not interfere with your duties and responsibilities. Reporting To: The Board Location: New York, NY Effective Date: May 1, 2019 Page 1 107451833v8


 
Annual Pay Rate (Base Salary): $1,000,000 You may be considered for an annual performance evaluation to increase (but not decrease) base salary as part of the standard performance evaluation cycle. Any corresponding pay adjustments will be based on your performance, business results, economic and competitive factors, and approval from the Board in its sole discretion. Incentive Compensation: Cash Bonus: From and after the Effective Date, you will continue to participate in the Incentive Compensation (“IC”) program at a target level of 150% of your annual base salary. Your initial annual target level (100% performance) is $1,500,000, provided, that such target level may be reviewed for increase, but not decrease other than in connection with an across-the-board reduction prior to a Change in Control (as defined below) that affects senior executives of the Company. Maximum annual payout is double your target level (i.e., 200% of target), or $3,000,000. Payments shall be made in the same form and timing as made to other senior executives of Ascena. The IC program is governed by the terms and conditions of the Ascena 2016 Omnibus Incentive Plan, as amended (or any successor plan) (the “2016 Plan”). Transformation Bonus: You will continue to participate in the Transformation Bonus Program at the same level in effect as of the Effective Date. Your participation and awards are subject to the terms and conditions of the Transformation Bonus Program plan and Award Agreements thereunder. Long Term Incentives: Simultaneously with the execution of this Letter, the Compensation and Stock Incentive Committee of the Board (the “Compensation Committee”) has approved and shall grant on the Effective Date a one-time long-term incentive award promotion grant of performance based equity (approximately 60% will be granted as Restricted Stock Units (“RSUs”) and approximately 40% will be granted as Non-Qualified Stock Options (“NQSOs”)) equal to a value of $3,850,000 on the Effective Date (the “Promotion Grant”). The number of RSUs granted pursuant to the Promotion Grant will be determined based on the closing price of the Company’s common stock on the date of grant and the number of NQSOs granted pursuant to the Promotion Grant will be determined using the Black-Scholes value of the NQSOs (as determined by the Company) as of the date of grant. The Promotion Grant will vest as follows, subject to your continued employment from the grant date through the applicable vesting date: 25% of each of the RSUs and NQSOs will be eligible to vest if the closing price of the Company’s common stock equals or exceeds $3 per share for a 20-consecutive trading day period on or prior to the third anniversary of the grant date (the “$3 Hurdle”); an additional 25% of each of the RSUs and NQSOs will be eligible to vest if the closing price of the Company’s common stock equals or exceeds $5 per share for a 20- consecutive trading day period on or prior to the third anniversary of the Page 2 107451833v8


 
grant date (the “$5 Hurdle”); and the remaining 50% of each of the RSUs and NQSOs will be eligible to vest if the closing price of the Company’s common stock equals or exceeds $7 per share for a 20-consecutive trading day period on or prior to the third anniversary of the grant date (the “$7 Hurdle” and together with the $3 Hurdle and $5 Hurdle, the “Hurdles”); provided, however, if the $3 Hurdle, $5 Hurdle and/or the $7 Hurdle is actually achieved prior to the second anniversary of the grant date, the portion of the RSUs and Options related to the achievement of the $3 Hurdle, $5 Hurdle and/or $7 Hurdle that was actually achieved prior to the second anniversary will vest on the second anniversary of the grant date, subject to your continued employment from the grant date through the second anniversary of the grant date, except as expressly provided herein. If the $3 Hurdle, $5 Hurdle and/or $7 Hurdle is not actually achieved by the third anniversary of the grant date, all RSUs and NQSOs that did not vest as of the third anniversary will be forfeited for no consideration. The Promotion Grant shall be subject to the terms and conditions of the 2016 Plan, applicable Award Agreements thereunder and Plan Description/Prospectus and is conditioned on your timely execution of the Restrictive Covenant Agreement (as defined below). Subject to your continued employment, you will next be considered for a long term incentive award grant during the first annual long term incentive award grant cycle occurring after the Effective Date (i.e., Fall 2019). The long term incentive awards granted to you in 2017, consisting of time- vested awards (the (“2017 Time-Vested Awards”), performance-vested awards (“2017 Performance-Vested Awards”) and an additional time- vested award (“Additional RSU”) will remain outstanding in accordance with the terms thereof. All grants are subject to the terms and conditions of the 2016 Plan, applicable Award Agreements and Plan Description/ Prospectus. and are conditioned upon your timely execution of, and compliance with, the Company’s restrictive covenant agreement containing a non-competition, non-solicitation and other provisions (“Restrictive Covenant Agreement”), which shall be substantially in the form provided to you previously, except that (i) your post-termination Non-Compete Period shall be for one year following your termination for any reason, (ii) your post-termination Non- Solicit Period shall be for two years following your termination for any reason, and (iii) such restrictions shall apply without any requirement of the Company to make additional payments to you in the event of your termination by the Company without “Cause” (as defined below) or your termination for “Good Reason” (as defined below) and if you are receiving severance payments and benefits as provided under this letter. In the event of your termination by the Company without Cause or your termination for Good Reason prior to a “Change in Control” (as defined in the Company’s Executive Severance Plan (“ESP”) as of June 1, 2017) (a Page 3 107451833v8


 
“Qualifying Termination”), the Promotion Grant will be treated as follows, subject to your timely execution and non-revocation of a release used in connection with the ESP (the “Release Condition”):  You will become vested in a pro rata portion of any outstanding and unvested RSUs and NQSOs for which the applicable Hurdle(s) were actually achieved prior to your Qualifying Termination. Such pro rata portion will be calculated by multiplying the number of RSUs and NQSOs eligible to vest based on the actual achievement of the applicable Hurdle by a fraction, the numerator of which is the number of days from the grant date of the Promotion Grant until the termination date and the denominator of which is 1,095. NQSOs that become vested on your Qualifying Termination will remain exercisable for 6 months but in no event later than the expiration date. In the event that your employment with the Company terminates due to your death or Disability (as defined in the 2016 Plan) prior to the second anniversary of the grant date of the Promotion Grant, then subject to your (or your estate’s or legal representative’s) satisfaction of the Release Condition, the portion of the RSUs and NQSOs for which the applicable Hurdle(s) were actually achieved prior to the date of termination will become immediately vested. NQSOs that become vested on your termination due to death or Disability will remain exercisable for 6 months but in no event later than the expiration date. In the event of your “Change in Control Related Termination” (as defined in the ESP as of June 1, 2017) and notwithstanding Section 2.2(c) of the ESP as of June 1, 2017, the Promotion Grant will be treated as follows:  In the event of your Post-Change in Control Termination (as defined in the ESP as of June 1, 2017), and provided that, on or prior to such Post-Change in Control Termination the $3 Hurdle has been satisfied, you will become vested in a portion of the RSUs and NQSOs based on linear interpolation (rounded to the nearest one- hundredth) between the (x) closing price of the Company’s common stock for the 20-consecutive trading day period immediately preceding the Post-Change in Control Termination (the “Termination Date Price”) and (y) the Hurdles between which the Termination Date Price falls (i.e., between the $3 Hurdle and $5 Hurdle or between $5 Hurdle and $7 Hurdle). By way of example only, if the Termination Date Price is $4, you will become vested in (i) the portion of the RSUs and NQSOs that vest based on the achievement of the $3 Hurdle to the extent not vested in accordance with this letter prior to the date of your Post-Change in Control Termination and (ii) an additional 50% of the tranche of the NQSOs and RSUs that would vest upon actual achievement of the $5 Hurdle (i.e., an additional 12.5% of the RSUs and NQSOs granted Page 4 107451833v8


 
pursuant to the Promotion Grant). If the Promotion Grant remains outstanding following the Change in Control, the Hurdles shall be reasonably adjusted to account for the impact of the Change in Control. Any portion of the RSUs and NQSOs granted pursuant to the Promotion Grant that do not vest based on this paragraph will be forfeited for no consideration on the date of your Post-Change in Control Termination.  In the event of your Pre-Change in Control Termination (as defined in the ESP as of June 1, 2017), and provided that, on or prior to the date that the Change in Control is consummated the $3 Hurdle has been satisfied, the cash payment you will receive pursuant to Section 2.2(c) of the ESP as of June 1, 2017, will include payment in respect of a portion of the RSUs and NQSOs based on linear interpolation (rounded to the nearest one-hundredth) between the (x) closing price of the Company’s common stock for the 20- consecutive trading day period immediately preceding the Change in Control (the “CIC Closing Date Price”) and (y) the Hurdles between which the CIC Closing Date Price falls (i.e., between the $3 Hurdle and $5 Hurdle or between $5 Hurdle and $7 Hurdle). By way of example only, if the CIC Closing Date Price is $4, the cash payment you will receive pursuant to Section 2.2(c) of the ESP as of June 1, 2017, will include payment in respect of (i) the portion of the RSUs and NQSOs that vest based on the achievement of the $3 Hurdle to the extent not vested in accordance with this letter prior to the date of your Pre-Change in Control Termination and (ii) an additional 50% of the tranche of the NQSOs and RSUs that would vest upon actual achievement of the $5 Hurdle (i.e., an additional 12.5% of the RSUs and NQSOs granted pursuant to the Promotion Grant). You will receive no payment under Section 2.2(c) of the ESP as of June 1, 2017, for any portion of the RSUs and NQSOs granted pursuant to the Promotion Grant that do not vest based on this paragraph will be forfeited for no consideration on the date the Change in Control is consummated. In the event of your Qualifying Termination, the long term incentive awards granted to you in 2017 will be treated as follows, subject to your satisfaction of the Release Condition; provided, that, more favorable treatment may be provided for a termination of employment without Cause or for Good Reason, in each case, in anticipation of a Change in Control:  To the extent that your 2017 Time-Vested Awards and/or the Additional RSU are outstanding and unvested at the time of any such Qualifying Termination, the next tranche of either such award scheduled to vest following any such Qualifying Termination will vest on the date of the Qualifying Termination; Page 5 107451833v8


 
 To the extent that your 2017 Performance-Vested Awards are outstanding and unvested at the time of any such Qualifying Termination, a pro rata portion of such awards will vest subject to the actual achievement of the applicable performance goals and following the certification of the goals by the Compensation Committee after the end of the applicable performance period. Such pro rata portion will be calculated by multiplying the amount of the award achieved upon the satisfaction of the applicable performance goals by a fraction, the numerator of which is the number of days from the grant date until the termination date and the denominator of which is the total days within the applicable performance period. All pay and benefits otherwise remain subject to the terms and conditions of the applicable plans, programs and policies. At Ascena, an employment at-will relationship prevails and the employment relationship can be terminated with or without Cause and with or without notice, at any time, by either the employee or the employer. You shall participate in the ESP, subject to its terms and conditions, provided, that any dispute in connection with the ESP shall be determined by de novo review notwithstanding any references to Committee authority under the ESP. Your participation in the ESP shall be modified as follows: (i) you shall be eligible for severance in the event of your termination by the Company without Cause (as defined in Section 1.5(b) of the ESP as of June 1, 2017, but modified as described under clause (ii) below) or termination by you for Good Reason (as defined in Section 1.22 of the ESP as of June 1, 2017 but modified as described under clause (iii) below), which definition shall apply to you regardless of the occurrence of a Change in Control (as defined in the ESP as of June 1, 2017); (ii) for purposes of your definition of “Cause,” (A) Section 1.5(a) shall be deleted and replaced with the following: “(a) conviction of a crime (including conviction or a nolo contendere plea) involving the commission by the Participant of a felony or of a criminal act involving, in the good faith judgment of the Board, fraud, dishonesty, or moral turpitude but excluding any conviction which results solely from the Participant’s title or position with Ascena and is not based on the Participant’s personal conduct;” and (B) Section 1.5(b) shall be deleted and replaced with the following: “(b) intentional and willful failure to satisfactorily perform employment duties reasonably requested by the Board after thirty (30) days’ written notice of such failure to perform, specifying that the failure constitutes cause (other than as a result of vacation, sickness, illness or injury);”. (iii) the definition of Good Reason shall also include any material breach of this letter by the Company or failure by Ascena to pay your compensation and benefits in accordance with this letter, in each case, subject to the notice and cure provisions in the ESP, and for purposes of your definition of “Good Reason,” Section 1.22(b) of the ESP shall be deleted and replaced with the following: “(b)(I) prior to a Change in Control, any reduction in the Participant’s base salary, other than a reduction that is uniformly applied to similarly situated employees of not more than 10%; and (II) on or after a Change in Control, any reduction in the Participant’s base salary and/or benefits, other than a reduction that is uniformly applied to similarly situated employees of not more than 10%;” Page 6 107451833v8


 
(iv) your cash severance payment level under Section 2.2(a)(i) of the ESP (relating to a non-change in control termination) shall be 24 months of base salary and your cash severance level under Section 2.2(a)(ii) of the ESP (relating to a change in control related termination) shall be 24 months of base salary and bonus (as defined in the ESP); (v) your Continuation Period (as defined in the ESP) shall not exceed 18 months; (vi) no mitigation provisions in the ESP shall be applicable to you, however, provisions related to set-off remain applicable to you; and (vii) if such ESP is adversely amended in any material manner or terminated, you shall nonetheless remain eligible for severance at the levels described herein, but you shall continue to be subject to the terms and conditions of the ESP as if it continued to apply to you without regard to any such amendment or termination. If your employment is terminated due to your death or Disability, then in addition to any vested and accrued benefits you are entitled to receive pursuant to the Company’s benefit plans and programs, and subject to your (or your estate’s or legal representative’s) satisfaction of the Release Condition, you (or your estate or legal representative) will be entitled to receive a pro rata portion (based on the number of days you were employed during the applicable performance period) of your seasonal IC for the performance period in which your termination occurs, calculated based on actual results for such performance period and paid at the same time seasonal IC bonuses are otherwise paid. Notwithstanding anything to the contrary, in no event shall there be any duplication of severance payments or benefits under any plan, program or policy, under this letter or under the Restrictive Covenant Agreement. Taxes: Any payments or benefits to be made or provided to you pursuant to this letter shall be subject to any withholding tax (including social security contributions and federal income taxes) as shall be required by federal, state and local withholding tax laws. This letter is intended to be exempt from, or comply with, the requirements of Section 409A of the Internal Revenue Code of 1986 and the guidance promulgated thereunder, and will be interpreted, administered and operated in a manner consistent with that intent. Each payment to you shall be treated as a separate payment, and any right to a series of installment payments is to be treated as a right to a series of separate payments. Payments and benefits that may be provided to you under the ESP shall be subject to Section 7.8 of the ESP. Entire Agreement: This letter sets forth the entire agreement and understanding between you and the Company relating to the subject matter hereof and supersedes any and all prior agreements, arrangements and understandings, written and oral, relating to the subject matter hereof, including the letter between you and the Company dated June 1, 2017, but excluding your Award Agreements under the 2016 Plan and your Award Agreements under the Transformation Bonus Program. Waiver and Release: In consideration of the terms, conditions and benefits, monetary and otherwise, set forth in this letter agreement, you hereby release and waive any and all legal and contractual claims and claims of entitlement, known or unknown, that you have or may have against Ascena and/or its affiliates, directors, officers or employees, based on any facts, events or circumstances occurring through the date you sign this letter, other than with respect to any outstanding equity awards or vested, accrued benefits you may have under the terms and conditions of any applicable plan or agreement. You hereby Page 7 107451833v8


 
acknowledge that you are not aware of any claims you may currently have against Ascena and/or its affiliates, directors, officers or employees. Please sign both copies of this letter, keep one for your records and return one to me. Once again, congratulations on your new position. Sincerely, I accept your offer as specified above. /s/ Kate Buggeln /s/ Gary Muto Kate Buggeln Gary Muto Lead Independent Director 4/29/19 5/1/19 Date Date Page 8 107451833v8


 
May 1, 2019 VIA EMAIL Carrie W. Teffner Dear Carrie: In connection with your appointment, effective May 1, 2019 (the “Appointment Date”), as Interim Executive Chair (“Interim Chair”) of the Board of Directors (the “Board”) of Ascena Retail Group, Inc. (“Ascena” or the “Company”), I am pleased to confirm the terms of your employment by the Company as Interim Chair. Duties and Responsibilities: As Interim Chair, you will perform the customary duties and responsibilities of such position, as well as such other duties commensurate with such position that you and the Board determine are appropriate for you to undertake. As Interim Chair, it is expected that you will devote substantially all of your working time, attention and energies to the business of Ascena, its subsidiaries and affiliated entities. You agree not to engage in any other business or employment without the written consent of the Board except as otherwise specifically provided herein, provided that you may continue to serve as a member of the board of directors of GameStop Corp. In addition, you may perform uncompensated services in connection with either the management of personal investments or with charitable or civic organizations, provided that such activities do not interfere with your duties and responsibilities. Effective as of the Appointment Date, you will continue to serve as a member of the Board, subject to the requirement that you stand for re- election to the Board when your term on the Board would otherwise expire. You will determine in good faith which of the Company’s offices you will work from based on the Company’s business needs. Base Salary and Benefits: Effective as of the Appointment Date and while you serve as Interim Chair, your base salary will be at an annualized rate of $1,000,000, payable in accordance with the Company’s normal payroll practices. Effective as of the Appointment Date, you will be eligible to participate in the retirement, health, life insurance and fringe benefit plans and programs Ascena makes available to its senior executives generally from time to time in accordance with the terms of such plans. Incentive Compensation: As of the Appointment Date, you will be eligible to participate in the 107530253v5


 
Company’s seasonal incentive compensation (“IC”) program at a target level of 150% of your base salary. Your annual target level (100% performance) is $1,500,000. Maximum annual payout is double your target level (i.e., 200% of target), or $3,000,000. Your IC for the season in which the Appointment Date occurs will be pro-rated based on the number of days you are employed from the Appointment Date through the end of the season. If earned, payments shall be made in the same form and timing as made to other senior executives of Ascena. The IC program is governed by the terms and conditions of the Ascena 2016 Omnibus Incentive Plan, as amended (or any successor plan) (the “2016 Plan”). Long Term Incentives: Simultaneously with the execution of this letter, the Compensation and Stock Incentive Committee of the Board (the “Compensation Committee”) has approved and shall grant on the Appointment Date a one-time long-term incentive award appointment grant of performance based equity (subject to applicable award limitations in the 2016 Plan, approximately 60% will be granted as Restricted Stock Units (“RSUs”) and approximately 40% will be granted as Non-Qualified Stock Options (“NQSOs”)) equal to a value of $1,050,000 on the Appointment Date (the “Appointment Grant”). The number of RSUs granted pursuant to the Appointment Grant will be determined based on the closing price of the Company’s common stock on the date of grant and the number of NQSOs granted pursuant to the Appointment Grant will be determined using the Black-Scholes value of the NQSOs (as determined by the Company) as of the date of grant. The Appointment Grant will vest as follows, subject to your continued employment as Interim Chair or service as a member of the Board, as applicable, from the grant date through the applicable vesting date: 25% of each of the RSUs and NQSOs will be eligible to vest if the closing price of the Company’s common stock equals or exceeds $3 per share for a 20-consecutive trading day period on or prior to the third anniversary of the grant date (the “$3 Hurdle”); an additional 25% of each of the RSUs and NQSOs will be eligible to vest if the closing price of the Company’s common stock equals or exceeds $5 per share for a 20- consecutive trading day period on or prior to the third anniversary of the grant date (the “$5 Hurdle”); and the remaining 50% of each of the RSUs and NQSOs will be eligible to vest if the closing price of the Company’s common stock equals or exceeds $7 per share for a 20-consecutive trading day period on or prior to the third anniversary of the grant date (the “$7 Hurdle” and together with the $3 Hurdle and $5 Hurdle, the “Hurdles”); provided, however, if the $3 Hurdle, $5 Hurdle and/or the $7 Hurdle is actually achieved prior to the second anniversary of the Appointment Date, the portion of the RSUs and Options related to the achievement of the $3 Hurdle, $5 Hurdle and/or $7 Hurdle that was actually achieved prior to the second anniversary of the Appointment Date will vest on the second anniversary of the Appointment Date, subject to your continued employment as Interim Chair or service as a member of the Board from the grant date through such second anniversary date, except as expressly provided herein. If the $3 Hurdle, $5 Hurdle and/or $7 Hurdle is not actually achieved by the third 107530253v5


 
anniversary of the grant date, all RSUs and NQSOs that did not vest as of the third anniversary will be forfeited for no consideration. The Appointment Grant shall be subject to the terms and conditions of the 2016 Plan, applicable Award Agreements thereunder and Plan Description/Prospectus and is conditioned on your timely execution of the Company’s standard Confidentiality, Non-Solicitation and Non- Competition Agreement. If your employment as Interim Chair ends due to the appointment of a Non-Executive Chair and you continue to serve as a member of the Board thereafter, the RSUs and NQSOs granted pursuant to the Appointment Grant will remain outstanding and eligible to vest in accordance with and subject to the terms and conditions of this letter. In the event (x) the Company terminates your employment as Interim Chair without Cause (as defined in the 2016 Plan) and you do not continue to serve on the Board after such termination or (y) of your Termination of Directorship (as defined in the 2016 Plan) other than due to (i) your resignation or (ii) your removal for “cause” under Delaware law while serving on the Board after your employment as Interim Chair ends due to the appointment of a Non-Executive Chair, in either case prior to a Change in Control (as defined in the 2016 Plan) (a “Qualifying Termination”), the Appointment Grant will be treated as follows, subject to your timely execution and non-revocation of the Company’s customary form of release of claims in favor of the Company and related parties (the “Release Condition”):  You will become vested in a pro rata portion of any outstanding and unvested RSUs and NQSOs for which the applicable Hurdle(s) were actually achieved prior to your Qualifying Termination. Such pro rata portion will be calculated by multiplying the number of RSUs and NQSOs eligible to vest based on the actual achievement of the applicable Hurdle by a fraction, the numerator of which is the number of days from the grant date of the Appointment Grant until the termination date and the denominator of which is 1,095. NQSOs that become vested on your Qualifying Termination will remain exercisable for 6 months but in no event later than the expiration date. In the event of your termination as Interim Chair or as a member of the Board due to your death or Disability (as defined in the 2016 Plan) prior to the second anniversary of the grant date of the Appointment Grant, then subject to your (or your estate’s or legal representative’s) satisfaction of the Release Condition, the portion of the RSUs and NQSOs for which the applicable Hurdle(s) were actually achieved prior to the date of such termination will become immediately vested. NQSOs that become vested on your termination due to death or Disability will remain exercisable for 6 months but in no event later than the expiration date. 107530253v5


 
In the event, upon a Change in Control (as defined in the 2016 Plan), (x) your employment as Interim Chair is terminated by the Company without Cause (as defined in the 2016 Plan) and you do not continue to serve as a member of the Board or (y) of your Termination of Directorship (as defined in the 2016 Plan) other than due to (i) your resignation or (ii) your removal for “cause” under Delaware law, in either case while serving on the Board after your employment as Interim Chair ends due to the appointment of a Non-Executive Chair ((x) or (y), each a “Change in Control Termination”), and provided that, on or prior to such Change in Control Termination the $3 Hurdle has been satisfied, you will become vested in a portion of the RSUs and NQSOs based on linear interpolation (rounded to the nearest one-hundredth) between the (x) closing price of the Company’s common stock for the 20-consecutive trading day period immediately preceding the Change in Control Termination (the “Termination Date Price”) and (y) the Hurdles between which the Termination Date Price falls (i.e., between the $3 Hurdle and $5 Hurdle or between $5 Hurdle and $7 Hurdle). By way of example only, if the Termination Date Price is $4, you will become vested in (i) the portion of the RSUs and NQSOs that vest based on the achievement of the $3 Hurdle to the extent not vested in accordance with this letter prior to the date of your Change in Control Termination and (ii) an additional 50% of the tranche of the NQSOs and RSUs that would vest upon actual achievement of the $5 Hurdle (i.e., an additional 12.5% of the RSUs and NQSOs granted pursuant to the Appointment Grant). If the Appointment Grant remains outstanding following the Change in Control, the Hurdles shall be reasonably adjusted to account for the impact of the Change in Control. Any portion of the RSUs and NQSOs granted pursuant to the Appointment Grant that do not vest based on this paragraph will be forfeited for no consideration on the date of your Change in Control Termination. If you resign (x) as Interim Chair and do not continue to serve on the Board or (y) from the Board after your employment as Interim Chair ends due to the appointment of a Non-Executive Chair, all outstanding and unvested RSUs and NQSOs subject to the Appointment Grant will be forfeited for no consideration as of the date of your resignation. While you serve as Interim Chair, long term incentive awards granted to you under the 2016 Plan prior to the Appointment Date in connection with your service as a member of the Board will continue to vest in accordance with the terms and conditions of the applicable Award Agreements and the 2016 Plan. No Board Compensation: Effective as of the Appointment Date and for so long as you serve as Interim Chair, you will not be entitled to any additional compensation, whether cash or equity, with respect to your service as a member of the Board. If you remain a member of the Board after you cease serving as Interim Chair, you will be eligible to receive compensation for such Board service in accordance with the Company’s non-employee director compensation program then in effect (subject to pro ration as 107530253v5


 
applicable). Committee Memberships: Effective as of the Appointment Date and for so long as you serve as Interim Chair, your membership on all standing committees of the Board and any committees requiring director independence under Nasdaq or SEC rules shall be suspended. Subject to Nasdaq and SEC independence rules and provided you remain a member of the Board, when you cease serving as Interim Chair, you will be permitted to resume membership on the standing committees of the Board of which you were a member immediately prior to the Appointment Date. Taxes: Any payments or benefits to be made or provided to you pursuant to this letter shall be subject to any withholding tax (including social security contributions and federal income taxes) as shall be required by federal, state and local withholding tax laws. This letter is intended to be exempt from, or comply with, the requirements of Section 409A of the Internal Revenue Code of 1986 and the guidance promulgated thereunder, and will be interpreted, administered and operated in a manner consistent with that intent. Governing Law: This letter shall be governed by and construed and enforced in accordance with the laws of the State of New York, without regard to conflicts of laws principles. While serving as Interim Chair, you will not be eligible to participate in any Company-sponsored severance plan, including the Company’s Executive Severance Plan. Upon termination of your employment as Interim Chair, you will not be entitled to any severance payments or termination benefits except as expressly provided herein with respect to the Appointment Grant. This letter sets forth the entire agreement and understanding between you and the Company regarding your service as Interim Chair, and supersedes any and all other agreements or understandings, whether written or oral, between you and the Company regarding the subject matter hereof, excluding Award Agreements under the 2016 Plan relating to awards granted to you prior to the Appointment Date. All pay and benefits otherwise remain subject to the terms and conditions of the applicable plans, programs and policies. Please sign both copies of this letter, keep one for your records and return one to me. Once again, congratulations on your new position. Sincerely, I accept your offer as specified above. /s/ Kate Buggeln /s/ Carrie W. Teffner Kate Buggeln Carrie W. Teffner Lead Independent Director 5/1/19 5/1/19 Date Date 107530253v5


 
May 1, 2019 VIA EMAIL Re: Robb Giammatteo Retention Offer Dear Robb: In recognition of your valued contributions and the desire of Ascena Retail Group, Inc. (the “Company”) to ensure your continued service with the Company as the Company completes Project Viking and explores and, if applicable, completes Projects Robin, Venus, and Iris, the Company is pleased to offer to you an opportunity to earn a Retention Bonus on the terms and conditions set forth in this letter (the “Agreement”). I. Amount and Payment Schedule for Retention Bonus The maximum possible amount of the Retention Bonus is $700,000, less applicable taxes and deductions. The Retention Bonus will be paid in equal installments as described below, as soon as reasonably practicable following each of the dates set forth below, but in no event later than 30 days following each of the dates set forth below. You must be continuously employed by the Company from the date of this Agreement through the payment date of the particular installment payment in order to receive the installment payment. Retention Bonus Installment Payment Amount Trigger or Date for Installment Payment $350,000 August 31, 2019 $350,000 August 31, 2020 II. Repayment of Retention Bonus In the event that, before the August 31, 2020 installment payment is paid to you as provided in Section I, you resign your employment for any reason whatsoever, or your employment is terminated due to: (i) a violation of company policy, (ii) conduct giving rise to immediate discharge, and/or (iii) “Cause” (as defined in the Company’s Executive Severance Plan, as may be amended from time to time (the “ESP”)) (clauses (i) through (iii), a “Company Termination”), then you will be responsible for repaying the Company (A) the net after-tax amount of the Retention Bonus paid to you prior to your resignation or (B) the gross amount of the Retention Bonus paid to you prior to your Company Termination. Any amount required to be repaid to the Company pursuant to this Section II must be paid in a cash lump sum within 90 days of your resignation or Company Termination, as applicable. 107501795v4


 
III. Severance Benefits Effective as of the date of this Agreement, in the event of your “Non-Change in Control Termination” (as defined in the ESP), your cash severance level under Section 2.2(a)(i) of the ESP will be 24 months of your then-current base salary. In addition, effective as of the date of this Agreement, in the event of your “Change in Control Related Termination” (as defined in the ESP), the multiple for your cash severance amount under Section 2.2(a)(ii) of the ESP shall be two times (2x) rather than one and one-half times (1.5x). Pursuant to Section 2.4 of the ESP, you will have no duty to mitigate severance payments that you may become eligible to receive under the ESP (as modified by this Agreement) and the Company will not reduce its obligation to pay any such severance by any amount that you may earn as base salary from a new employer. Your eligibility to receive severance benefits under the ESP is subject in all respects to the terms, conditions and restrictions of the ESP. If you resign your employment for any reason or your employment is terminated by the Company for any reason other than due to a Non-Change in Control Termination or a Change in Control Related Termination, you will not be eligible for any severance payments from the Company under this Agreement, the ESP or otherwise. IV. No Guarantee of Employment Your employment with the Company remains at will, and this Agreement does not constitute a contract of employment or guarantee or imply any right to continued employment for any period. V. Governing Law The Parties agree that this Agreement shall be construed in accordance with New York law, without regard to conflicts of laws principles. Any dispute arising out of, or relating to this Agreement, shall be subject to the exclusive jurisdiction of the state or federal courts of New York located in New York County. VI. Return of Agreement If you wish to be eligible to receive the Retention Bonus and the ESP modifications set forth herein, please sign and return the Agreement to Heidi Mader no later than five business days from the date you received this Agreement. If you do not return the signed Agreement within this timeframe, this Agreement will be deemed revoked and of no effect, and you will not have any entitlement to the Retention Bonus or the ESP modifications set forth herein. VII. Taxes Any payments or benefits to be made or provided to you pursuant to this Agreement shall be subject to any withholding tax (including social security contributions and federal income taxes) as shall be required by federal, state and local withholding tax laws. This Agreement is intended to be exempt from, or comply with, the requirements of Section 409A of the Internal Revenue Code of 1986 and the guidance promulgated thereunder (“Section 409A”), and will be interpreted, administered and operated in a manner consistent with that intent. Each payment to you shall be treated as a separate payment, and any right to a series of installment payments is to be treated as a right to a series of separate payments. The Company shall have no liability to you or otherwise if the Retention Bonus is subject to Section 409A. 2 107501795v4


 
Payments and benefits that may be provided to you under the ESP shall be subject to Section 7.8 of the ESP. 3 107501795v4


 
Thank you for your continued work and dedication to the Company in support of these important initiatives. Best Regards, /s/ Gary Muto Gary Muto CEO, Ascena Retail Group, Inc. Accepted by: /s/ Robb Giammatteo __________________________________ Robb Giammatteo May 1, 2019 __________________________________ Date 4 107501795v4


 
ASCENA RETAIL GROUP ANNOUNCES SENIOR MANAGEMENT CHANGES --DAVID JAFFE, CHAIRMAN AND CEO TO RETIRE; GARY MUTO NAMED CEO CARRIE TEFFNER BECOMES INTERIM EXECUTIVE CHAIR OF THE BOARD --Move Reflects Company’s Ongoing Transformation-- Mahwah, N.J., (May 1, 2019) —ascena retail group, inc. (Nasdaq: ASNA) (“ascena” or the “Company”) today announced changes in its senior management structure. David Jaffe will retire from his role as Chairman and Chief Executive Officer, effective today. He will remain on the Board of Directors. Gary Muto, currently President and Chief Executive Officer of ascena brands, has been named the Company’s Chief Executive Officer and will join the ascena Board of Directors. In addition, Carrie Teffner has been named Interim Executive Chair of the Board of Directors. “Leading ascena over the past twenty-seven years has been a privilege. As the Company continues its transformation, the Board of Directors and I mutually agreed that these decisions are right for the business and its shareholders. I am extremely confident in ascena’s future under Gary’s leadership and look forward to continuing to serve ascena as a member of the Board,” said Mr. Jaffe. “I am both honored and excited by this new challenge. David, Carrie, the Board and I are working together to ensure the leadership transition is smooth,” said Mr. Muto. “And, I am eager to lead and work with our ascena associates, who share my deep commitment to our customers, brands and shareholders. Together we will realize ascena’s potential as the Board and management continue to execute on our previously announced strategic initiatives, including a comprehensive assessment of ascena’s portfolio brands, operations, assets and continued cost savings.” “On behalf of the Board, I want to thank David for his many years of service to ascena’s customers, associates and communities. During his watch, the Company built solid organizational and functional capabilities as well as a deep executive bench. We are pleased that David will continue to serve ascena as a member of our Board. I also want to thank Carrie Teffner for stepping into the role of Interim Executive Chair. Carrie will work closely with Gary to accelerate and amplify execution of the Company’s strategic initiatives,” said Kate Buggeln, Lead Independent Director of ascena retail group, inc. The Company also announced the departure of Brian Lynch, President and COO. “I want to thank Brian for his contributions to ascena. Among his accomplishments, Brian led ascena’s Change for Growth transformation plan which is on track to deliver a run rate cost savings of $300 million by July 2019,” said Mr. Jaffe. In connection with her appointment, Ms. Teffner has stepped down from her committee positions. Chuck Rubin has been appointed as the Chair of the Audit Committee and Linda Yaccarino has been appointed as the Chair of the Compensation and Stock Incentive Committee. 1


 
Biographies Gary Muto Gary Muto is a seasoned retail leader with an extensive career and impressive track record. Mr. Muto joined ANN INC. / ascena retail group, inc. in 2008 as the President of LOFT. In 2013, he assumed responsibility for leading the Ann Taylor, LOFT and Lou & Grey brands. In August 2017, he was promoted to President and Chief Executive Officer of ascena brands, a role which included reinvigorating and driving top-line growth across ascena’s full brand portfolio. Between 1998 and 2007, Mr. Muto held several leadership roles at Gap Inc., including President of Banana Republic and President of Gap brands. While at Gap Inc., Mr. Muto also launched the specialty brand, Forth & Towne. After earning his Bachelor of Science degree in Marketing from St. John’s University, Mr. Muto started his retail career as a Group Buyer at Abraham & Straus. Carrie W. Teffner Carrie Teffner has been a member of the ascena Board of Directors since 2018, and until her appointment as Interim Executive Chair, served as Chair of the Audit Committee and as a member of the Compensation and Stock Incentive Committee. Ms. Teffner joined Crocs Inc. (“Crocs”) as a member of Board of Directors in 2015. Six months later, she was asked to assume responsibilities as Executive Vice President and Chief Financial Officer. Prior to her departure in April 2019, Ms. Teffner served as Crocs’ Executive Vice President of Finance and Strategic Projects. Prior to Crocs, Ms. Teffner served as Executive Vice President and Chief Financial Officer of PetSmart, Inc. (2013 – 2015) where she was responsible for finance and IT. Ms. Teffner also served as Executive Vice President and Chief Financial Officer of Weber Stephen Products LLC (2011-2013) and the Timberland Company, as Senior Vice President and Chief Financial Officer (2009-2011). Since 2018, she has been a Director of GameStop Corp. Ms. Teffner spent the first 21 years of her career with Sara Lee Corporation where she held various domestic and international positions including divisional and segment CFO roles as well as serving as Global Treasurer. About ascena retail group, inc. ascena retail group, inc. (Nasdaq: ASNA) is a leading national specialty retailer offering apparel, shoes, and accessories for women under the Premium Fashion segment (Ann Taylor, LOFT, and Lou & Grey), Value Fashion segment (maurices and dressbarn), Plus Fashion segment (Lane Bryant, Catherines and Cacique), and for tween girls under the Kids Fashion segment (Justice). ascena retail group, inc. operates ecommerce websites and approximately 4,500 stores throughout the United 2


 
States, Canada and Puerto Rico. For more information about ascena retail group, inc. visit: ascenaretail.com, AnnTaylor.com, factory.anntaylor.com, LOFT.com, outlet.loft.com, louandgrey.com, maurices.com, dressbarn.com, lanebryant.com, Catherines.com, and shopjustice.com. Forward-Looking Statements Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties. Actual results could differ materially from such forward-looking information. ascena’s Securities and Exchange Commission (“SEC”) filings identify many such risks and uncertainties. The forward-looking information in this press release could be affected by many factors, including, without limitation, risks associated with the ability to retain key personnel, changes in financial markets, interest rates and foreign currency exchange rates, the ability to achieve anticipated cost reductions, the ability to achieve a successful outcome for its portfolio brands and to otherwise achieve its business strategies, and those additional risks and factors discussed in reports filed with the SEC by ascena from time to time, including those discussed under the heading “Risk Factors” in its most recently filed Annual Report on Form 10-K. We undertake no duty and have no obligation to update any forward-looking statements contained herein. CONTACT: For investors: For media: ICR, Inc. ascena retail group, inc. Jean Fontana Shawn Buchanan Managing Director Corporate Communications (646) 277-1214 (212) 541-3418 Jean.Fontana@icrinc.com shawn_buchanan@ascenaretail.com Jennifer Davis Senior Vice President (646) 677-1813 Jennifer.Davis@icrinc.com 3